Related references
Note: Only part of the references are listed.Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)
Daniel J. Lee et al.
BJU INTERNATIONAL (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
Terence W. Friedlander et al.
CANCER RESEARCH (2012)
Chromothripsis and Human Disease: Piecing Together the Shattering Process
Christopher A. Maher et al.
CELL (2012)
Prostate cancer and inflammation: the evidence
Karen S. Sfanos et al.
HISTOPATHOLOGY (2012)
Can Genomics Bend the Cost Curve?
Katrina Armstrong
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
Chunxiao Wu et al.
JOURNAL OF PATHOLOGY (2012)
Next Generation Sequencing of Prostate Cancer from a Patient Identifies a Deficiency of Methylthioadenosine Phosphorylase, an Exploitable Tumor Target
Colin C. Collins et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Comrad: detection of expressed rearrangements by integrated analysis of RNA-Seq and low coverage genome sequence data
Andrew McPherson et al.
BIOINFORMATICS (2011)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens et al.
CELL (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety
Himisha Beltran et al.
EUROPEAN UROLOGY (2011)
The advent of personal genome sequencing
Radoje Drmanac
GENETICS IN MEDICINE (2011)
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Yusuke Shiozawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CANCER When catastrophe strikes a cell
Jose M. C. Tubio et al.
NATURE (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation
Delila Gasi et al.
PLOS ONE (2011)
Molecular classification of prostate cancer using curated expression signatures
Elke K. Markert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Use of Irinotecan for Treatment of Small Cell Carcinoma of the Prostate
Wei-Lin Tung et al.
PROSTATE (2011)
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
Sameek Roychowdhury et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
An EMT-Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
Irina M. Shapiro et al.
PLOS GENETICS (2011)
Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments
James H. Bullard et al.
BMC BIOINFORMATICS (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples
Yohei Miyagi et al.
MODERN PATHOLOGY (2010)
TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
Samson W. Fine et al.
MODERN PATHOLOGY (2010)
Clusterin Facilitates COMMD1 and I-kappa B Degradation to Enhance NF-kappa B Activity in Prostate Cancer Cells
Amina Zoubeidi et al.
MOLECULAR CANCER RESEARCH (2010)
Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
Anna Lapuk et al.
MOLECULAR CANCER RESEARCH (2010)
Alternative expression analysis by RNA sequencing
Malachi Griffith et al.
NATURE METHODS (2010)
The Pfam protein families database
Robert D. Finn et al.
NUCLEIC ACIDS RESEARCH (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Expression and prognostic role of syndecan-2 in prostate cancer
A. Popovic et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Hormone therapy in the management of prostate cancer: evidence-based approaches
Leonard G. Gomella et al.
THERAPEUTIC ADVANCES IN UROLOGY (2010)
Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin α2
Sojoong Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer
Chunru Lin et al.
CELL (2009)
Circos: An information aesthetic for comparative genomics
Martin Krzywinski et al.
GENOME RESEARCH (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer
Xiao-Song Wang et al.
NATURE BIOTECHNOLOGY (2009)
ETS gene fusions in prostate cancer
Jeremy P. Clark et al.
NATURE REVIEWS UROLOGY (2009)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Chromatin crosstalk in development and disease: lessons from REST
Lezanne Ooi et al.
NATURE REVIEWS GENETICS (2007)
Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors
Dragan Maric et al.
JOURNAL OF NEUROSCIENCE (2007)
Comparative genomics modeling of the NRSF/REST repressor network: From single conserved sites to genome-wide repertoire
Ali Mortazavi et al.
GENOME RESEARCH (2006)
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes
Jean-Claude Cutz et al.
CLINICAL CANCER RESEARCH (2006)
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer
Vincenzo Pagliarulo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Unbalanced alternative splicing and its significance in cancer
JP Venables
BIOESSAYS (2006)
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
N Vashchenko et al.
EUROPEAN UROLOGY (2005)
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors
PL Paris et al.
HUMAN MOLECULAR GENETICS (2004)
Diagnostic and therapeutic management of cancer of an unknown primary
N Pavlidis et al.
EUROPEAN JOURNAL OF CANCER (2003)
Synapse formation is regulated by the signaling adaptor GIT1
HY Zhang et al.
JOURNAL OF CELL BIOLOGY (2003)
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy
M Graefen et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes
MA Hakimi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer
M Graefen et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
